1. Comparison between various fracture risk assessment tools

   • W. D. Leslie
   • L. M. Lix

   Review 25 June 2013 Pages: 1 - 21

   

2. Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review

   • S. Nayak
   • D. L. Edwards
   • S. L. Greenspan

   Review 09 October 2013 Pages: 23 - 49

   

3. A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures

   • L. Si
   • T. M. Winzenberg
   • A. J. Palmer

   Review 24 October 2013 Pages: 51 - 60

   

4. FRAX provides robust fracture prediction regardless of socioeconomic status

   • S. L. Brennan
   • W. D. Leslie
   • J. A. Kanis

   Original Article 05 November 2013 Pages: 61 - 69

   

5. The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease

   • S. A. Jamal
   • S. L. West
   • T. L. Nickolas

   Original Article 11 October 2013 Pages: 71 - 76

6. Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial

   • D. Prieto-Alhambra
   • A. Judge
   • M. K. Javaid

   Original Article 28 June 2013 Pages: 77 - 83

   

7. Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study

   • C. L. Gregson
   • E. M. Dennison
   • for the GLOW Investigators

   Original Article 25 July 2013 Pages: 85 - 95

   

8. Association between hypertension and fragility fracture: a longitudinal study

   • S. Yang
   • N. D. Nguyen
   • T. V. Nguyen

   Original Article 27 July 2013 Pages: 97 - 103

   

9. Association between use of benzodiazepines and risk of fractures: a meta-analysis

   • D. Xing
   • X. L. Ma
   • Y. Chen

   Original Article 07 September 2013 Pages: 105 - 120

   

10. β-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects

    • K. A. Toulis
    • K. Hemming
    • J. P. Bilezikian

    Original Article 10 October 2013 Pages: 121 - 129

    

11. Low holotranscobalamin and cobalamins predict incident fractures in elderly men: the MrOS Sweden

    • C. Lewerin
    • H. Nilsson-Ehle
    • D. Mellström

    Original Article 16 October 2013 Pages: 131 - 140

    

12. Coffee, tea, and the risk of hip fracture: a meta-analysis

    • J. Sheng
    • X. Qu
    • K. Dai

    Original Article 06 November 2013 Pages: 141 - 150

    

13. Fracture risk following bariatric surgery: a population-based study

    • K. M. Nakamura
    • E. G. C. Haglind
    • K. A. Kennel

    Original Article 03 August 2013 Pages: 151 - 158

    

14. Incidence and risk factors for hip fractures in dialysis patients

    • M. Maravic
    • A. Ostertag
    • M. Cohen-Solal

    Original Article 09 July 2013 Pages: 159 - 165

    

15. Gender-specific hip fracture risk in community-dwelling and institutionalized seniors age 65 years and older

    • M. Finsterwald
    • E. Sidelnikov
    • H. A. Bischoff-Ferrari

    Original Article 18 October 2013 Pages: 167 - 176

    

16. Exploring the determinants of fracture risk among individuals with spinal cord injury

    • D. Lala
    • B. C. Craven
    • L. M. Giangregorio

    Original Article 28 June 2013 Pages: 177 - 185

    

17. Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults

    • D. Scott
    • A. Hayes
    • G. Jones

    Original Article 26 June 2013 Pages: 187 - 193

    

18. Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation

    • D. A. Eekman
    • M. M. ter Wee
    • W. F. Lems

    Original Article 27 September 2013 Pages: 195 - 204

    

19. Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces

    • R. G. Crilly
    • M. Kloseck
    • J. Gilliland

    Original Article 02 August 2013 Pages: 205 - 210

    

20. Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989–2008

    • K. Siggeirsdottir
    • T. Aspelund
    • G. Sigurdsson

    Original Article 02 July 2013 Pages: 211 - 219

    

21. Erratum to: Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989–2008

    • K. Siggeirsdottir
    • T. Aspelund
    • G. Sigurdsson

    Erratum 22 October 2013 Pages: 221 - 221

22. Effect of increased fruit and vegetable consumption on bone turnover in older adults: a randomised controlled trial

    • C. E. Neville
    • I. S. Young
    • J. V. Woodside

    Original Article 29 May 2013 Pages: 223 - 233

    

23. Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures

    • H. Johansson
    • A. Odén
    • J. A. Kanis

    Original Article 22 August 2013 Pages: 235 - 241

    

24. Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic range

    • K. Nassar
    • S. Paternotte
    • K. Briot

    Original Article 01 October 2013 Pages: 243 - 249

    

25. Distribution of bone density and cortical thickness in the proximal femur and their association with hip fracture in postmenopausal women: a quantitative computed tomography study

    • L. Yang
    • W. J. M. Udall
    • R. Eastell

    Original Article 30 May 2013 Pages: 251 - 263

    

26. Physical activity as determinant of femoral neck strength relative to load in adult women: findings from the hip strength across the menopause transition study

    • T. Mori
    • S. Ishii
    • A. S. Karlamangla

    Original Article 28 June 2013 Pages: 265 - 272

    

27. Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women?

    • S. L. Brennan
    • W. D. Leslie
    • L. M. Lix

    Original Article 02 August 2013 Pages: 273 - 279

    

28. Non-pharmacological strategies used by patients at high risk for future fracture to manage fracture risk—a qualitative study

    • J. E. M. Sale
    • M. A. Gignac
    • V. Elliot-Gibson

    Original Article 06 June 2013 Pages: 281 - 288

29. Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy’s fracture clinic screening program

    • D. E. Beaton
    • S. Dyer
    • The Osteoporosis Fracture Clinic Screening Program Evaluation Team

    Original Article 21 June 2013 Pages: 289 - 296

    

30. The Auckland calcium study: 5-year post-trial follow-up

    • L. T. Radford
    • M. J. Bolland
    • I. R. Reid

    Original Article 10 October 2013 Pages: 297 - 304

    

31. A parallel group double-blind RCT of vitamin D₃ assessing physical function: is the biochemical response to treatment affected by overweight and obesity?

    • A. D. Wood
    • K. R. Secombes
    • H. M. Macdonald

    Original Article 28 August 2013 Pages: 305 - 315

    

32. Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass

    • J. Zhang
    • E. Delzell
    • K. G. Saag

    Original Article 28 August 2013 Pages: 317 - 324

    

33. Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm

    • K. Kim
    • A. Svedbom
    • J. A. Kanis

    Original Article 10 October 2013 Pages: 325 - 337

    

34. The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis

    • P. Hadji
    • D. Felsenberg
    • A. Kurth

    Original Article 03 October 2013 Pages: 339 - 347

    

35. Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies

    • P. D. Miller
    • R. R. Recker
    • D. Masanauskaite

    Original Article 18 October 2013 Pages: 349 - 357

    

36. Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial

    • C. Meier
    • C. Kraenzlin
    • M. E. Kraenzlin

    Original Article 22 November 2013 Pages: 359 - 366

    

37. Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis—a double-blind, randomized, dose-finding study

    • T. Nakamura
    • M. Shiraki
    • S. Uchida

    Original Article 29 May 2013 Pages: 367 - 376

    

38. An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide

    • R. Niimi
    • T. Kono
    • A. Sudo

    Original Article 29 June 2013 Pages: 377 - 384

    

39. Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial

    • C. Klop
    • F. de Vries
    • M. L. Bouvy

    Original Article Open access 13 November 2013 Pages: 385 - 392

    

40. Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab

    • A. Neuprez
    • S. Coste
    • J. Y. Reginster

    Case Report Open access 09 July 2013 Pages: 393 - 395